UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000036063 |
|---|---|
| Receipt number | R000041078 |
| Scientific Title | EFFICACY AND SAFETY OF SUBSEQUENT MOLECULAR TARGETED THERAPY AFTER IMMUNO-CHECKPOINT THERAPY, RETROSPECTIVE STUDY OF JAPANESE METASTATIC RENAL CELL CARCINOMA PATIENTS (AFTER I-O Study) |
| Date of disclosure of the study information | 2019/03/01 |
| Last modified on | 2021/03/02 15:49:10 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/03/01 16:55:03 | ||
| 2 | Update | 2019/03/05 10:52:18 | Target sample size |
|
| 3 | Update | 2019/07/10 17:00:46 | Recruitment status Date of IRB Last follow-up date |
|
| 4 | Update | 2020/03/18 14:09:41 | Date analysis concluded |
|
| 5 | Update | 2021/03/01 11:22:13 | Recruitment status |
|
| 6 | Update | 2021/03/01 11:26:12 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 7 | Update | 2021/03/02 15:49:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email1 Organization Organization Address Address Tel |
